SEC Form 4 · accession 0001140361-16-087167
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J. Farrell
Officer — Chief Executive Officer
Period of report
Nov 16, 2016
Accepted (ET)
Nov 18, 2016 · 11:15 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | holding | — | — | — | 174,450 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock OptionsF1 | $57.76 | Nov 16, 2016 | A | 139,665 | A | Nov 11, 2017 | Nov 16, 2023 | ResMed Common Stock | 139,665 | 139,665 | D |
Explanation of responses
- F1Represents date options first become exercisable. Options vest 1/3 annually each November 11, 2017, 2018 and 2019.